3M (MMM) Stock Could Be 4.5% Undervalued After Airbus Deal And Upbeat Q2 Update - simplywall.st
π 3M stock has returned 11.28% over the last 90 days and 12.65% over one year following a constructive investor outlook.
βοΈ A new long-term insulation supply agreement has been secured with Airbus for the A220 aircraft program.
π° Analysts estimate a fair value of $170.97, suggesting the current price of $163.22 represents a 4.5% discount.
π New product launches accelerated by 70% year-over-year with a target of 215 launches for the current year.
π Five-year innovation sales have risen 9%, expected to exceed 15% growth annually to support revenue and margins.
β οΈ The bullish narrative hinges on favorable outcomes regarding PFAS legal challenges.
π‘οΈ Investors must evaluate if the company can successfully lift margins without its Solventum healthcare business segment.
- 3M secured a significant new long-term insulation supply agreement with Airbus for the A220 aircraft, providing a durable revenue stream.
- The stock has delivered an 11.28% return over the last 90 days and a 12.65% total shareholder return over the past year, indicating strong recent momentum.
- New product launches accelerated by 70% year-over-year with a target of 215 launches for the year, signaling robust innovation pipeline execution.
- Five-year innovation sales grew 9% and are expected to surpass 15% growth annually, supporting future revenue expansion and margin potential.
- Analyst fair value estimates suggest the stock is currently trading at a 4.5% discount to its intrinsic value of $170.97.
- The positive investment narrative for 3M remains contingent on favorable outcomes in ongoing PFAS legal cases.
- Investors face uncertainty regarding the company's ability to maintain or improve margins without its recently spun-off Solventum healthcare business.
- Market skepticism exists over whether current stock prices already fully price in the anticipated future growth from new product launches.